Exosens

ENXTPA:EXENS Stock Report

Market Cap: €2.5b

Exosens Past Earnings Performance

Past criteria checks 3/6

Exosens has been growing earnings at an average annual rate of 83.2%, while the Aerospace & Defense industry saw earnings growing at 27.1% annually. Revenues have been growing at an average rate of 22.1% per year. Exosens's return on equity is 13%, and it has net margins of 12.9%.

Key information

83.16%

Earnings growth rate

121.63%

EPS growth rate

Aerospace & Defense Industry Growth6.10%
Revenue growth rate22.05%
Return on equity12.97%
Net Margin12.91%
Next Earnings Update23 Feb 2026

Recent past performance updates

Recent updates

Calculating The Intrinsic Value Of Exosens (EPA:EXENS)

Oct 27
Calculating The Intrinsic Value Of Exosens (EPA:EXENS)

Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly

Sep 15
Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly

Exosens (EPA:EXENS) Released Earnings Last Week And Analysts Lifted Their Price Target To €41.21

Aug 03
Exosens (EPA:EXENS) Released Earnings Last Week And Analysts Lifted Their Price Target To €41.21

Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 26% Above Its Share Price

Jul 25
Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 26% Above Its Share Price

Exosens (EPA:EXENS) Might Have The Makings Of A Multi-Bagger

Jul 06
Exosens (EPA:EXENS) Might Have The Makings Of A Multi-Bagger

Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly

Jun 13
Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly
User avatar

Elevated Defense Spending Will Challenge Overvaluation And Unleash Upside

Growth and profitability expectations rely on sustained global defense spending, rapid demand capture, and seamless operational execution, making them vulnerable to defense cycle shifts and integrati

Market Participants Recognise Exosens' (EPA:EXENS) Revenues Pushing Shares 27% Higher

May 29
Market Participants Recognise Exosens' (EPA:EXENS) Revenues Pushing Shares 27% Higher

€31.58 - That's What Analysts Think Exosens (EPA:EXENS) Is Worth After These Results

Mar 06
€31.58 - That's What Analysts Think Exosens (EPA:EXENS) Is Worth After These Results

Optimistic Investors Push Exosens (EPA:EXENS) Shares Up 37% But Growth Is Lacking

Mar 05
Optimistic Investors Push Exosens (EPA:EXENS) Shares Up 37% But Growth Is Lacking

Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 96% Above Its Share Price

Feb 14
Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 96% Above Its Share Price

Revenue & Expenses Breakdown

How Exosens makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:EXENS Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 25432561280
31 Mar 25413411210
31 Dec 24394261150
30 Sep 24374141080
30 Jun 24354-31040
31 Mar 243232940
31 Dec 232927850
31 Dec 222011650
31 Dec 21166-149580
31 Dec 20150-16530

Quality Earnings: EXENS has high quality earnings.

Growing Profit Margin: EXENS became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EXENS has become profitable over the past 5 years, growing earnings by 83.2% per year.

Accelerating Growth: EXENS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: EXENS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Aerospace & Defense industry (13.1%).


Return on Equity

High ROE: EXENS's Return on Equity (13%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/03 03:56
End of Day Share Price 2025/10/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Exosens is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Amelie Dueckelmann-DublanyBerenberg
Laurent GelebartBNP Paribas
Charles ArmitageCitigroup Inc